ImmunoCellular Therapeutics, Ltd., based in Los Angeles, is developing immune-based therapies for the treatment of cancer. ImmunoCellular is focused on advancing its Stem-to-T-Cell research program, which engineers hematopoietic stem cells to generate cytotoxic T cells. Additional assets, for which the Company is seeking partners, include clinical-stage programs - ICT-107, ICT-121 and ICT-140 - which are patient-specific, dendritic cell-based immunotherapies targeting solid tumors.
Location: United States, California, Westlake Village
Phone: +1 818-264-2300
Investors 1
| Date | Name | Website |
| - | Asset Mana... | assetman.c... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 28.06.2021 | ImmunoCell... | LOS ANGELES, June 28, 2021 /... | - | - | prnewswire... |
| 02.01.2013 | A two-pron... | TVAX’s approach to immunothera... | - | - | medcitynew... |
| - | A two-pron... | UPDATED 1/7/13 After withdraw... | - | - | medcitynew... |